Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Correlation between anti-interferon-β binding and neutralizing antibodies in interferon-β-treated multiple sclerosis patients.
Randomized trial of oral teriflunomide for relapsing multiple sclerosis.
A study comparing the effectiveness and safety of teriflunomide and interferon beta-1a in patients with relapsing multiple sclerosis (TENERE)
Relapses Requiring Intravenous Steroid Use and Multiple-Sclerosis-Related Hospitalizations: Integrated Analysis of the Delayed-Release Dimethyl Fumarate Phase III Studies.
Therapeutic plasma exchange and pregnancy: A case report and guidelines for performing plasma exchange in a pregnant patient.
The cost of multiple sclerosis drugs in the US and the pharmaceutical industry: too big to fail?
Immunosuppressive therapy reduces axonal damage in progressive multiple sclerosis.
Interleukin-1beta promotes repair of the CNS.
An older dog with newer tricks: Predicting efficacy of IFN-β treatment for multiple sclerosis.
Risk of early relapse following the switch from injectables to oral agents for multiple sclerosis.
Episode 12 with Professor Gavin Giovannoni on the potential for finding a cure for MS.
Prevalence of cutaneous adverse events associated with long-term disease-modifying therapy and their impact on health-related quality of life in patients with multiple sclerosis: a cross-sectional study.
Birth Outcomes in Newborns Fathered by Men with Multiple Sclerosis Exposed to Disease-Modifying Drugs.
A randomized study of two interferon-beta treatments in relapsing-remitting multiple sclerosis.
B1 cells are unaffected by immune modulatory treatment in remitting-relapsing multiple sclerosis patients.
Antibody to α4 integrin suppresses natural killer cells infiltration in central nervous system in experimental autoimmune encephalomyelitis.
Masitinib in the treatment of active rheumatoid arthritis: results of a multicentre, open-label, dose-ranging, phase 2a study.
Safety and Clinical Outcomes of Rituximab Treatment in Patients with Multiple Sclerosis and Neuromyelitis Optica: Experience from a National Online Registry (GRAID).
Primary results of DECIDE: a randomized, double-blind, double-dummy, active-controlled trial of daclizumab HYP vs. Interferon β-1a in RRMS patients
17 beta-estradiol inhibits cytokine, chemokine, and chemokine receptor mRNA expression in the central nervous system of female mice with experimental autoimmune encephalomyelitis.
The Brain as a Target of Inflammatory Processes
Glial Biology: Functional Interactions Among Glia & Neurons (Gordon Research Seminar)
Mechanism of action of mitoxantrone.
Treatment patterns in disease-modifying therapy for patients with multiple sclerosis in the United States.
The differential diagnosis of neurological diseases by fractionating electrophoretically the CSF gamma-globulins.

Pages